Epidemiological Cohort · Urban Bangladesh · Since 2016

BELIEVE-UrbanSTUDY
Bangladesh Longitudinal Investigation of Emerging Vascular and Non-vascular Events

A prospective cohort of nearly 60,000 residents in Mirpur, Dhaka, investigating how environmental, behavioural and biological factors shape non-communicable diseases — a collaboration between NHFH&RI and the University of Cambridge.

59,844
Participants
31,713
Households
>300
Variables
2016
Study start
59,844
Participants Recruited
Mirpur, Dhaka
31,713
Households
Urban catchment
>300
Questionnaire Variables
Per participant
~2,000
Nightingale DBS Pilot
Paired samples
50%
Round 3 Reassessed
Follow-up ongoing
About the Cohort

A living bioresource for NCD epidemiology in Bangladesh

Initiated in 2016 to address the growing burden of non-communicable diseases, BELIEVE-Urban is one of the largest prospective cohorts ever assembled in Bangladesh.

The BELIEVE Urban Study is a large population-based prospective cohort conducted in Mirpur, Dhaka, as part of the broader Bangladesh Longitudinal Investigation of Emerging Vascular and Non-vascular Events. It was initiated in 2016 to establish a high-quality epidemiological platform for long-term research on cardiovascular and metabolic disorders.

The cohort includes 59,844 participants recruited from 31,713 households within the Mirpur urban catchment area. The study is implemented by the Department of Epidemiology and Research at the National Heart Foundation Hospital & Research Institute (NHFH&RI) in collaboration with the University of Cambridge, and is locally led by Professor Sohel Reza Choudhury.

The primary objective is to examine the determinants and progression of major non-communicable diseases — particularly cardiovascular disease, diabetes, hypertension and other metabolic disorders. The study integrates demographic, socioeconomic, behavioural, environmental, clinical and biological data so investigators can explore the complex interactions between social, environmental and biological determinants of disease.

Participants undergo baseline assessment including questionnaire-based interviews, anthropometry, blood pressure evaluation and biological sample collection. Specimens support biochemical testing and advanced molecular analyses — including genomics and proteomics — enabling investigation of the pathways that underlie cardiovascular and metabolic disease.

Follow-up rounds are conducted periodically to identify incident events and track changes in risk profiles. The third round of follow-up is currently under way, with around 50% of participants already reassessed. Findings from the cohort aim to inform national prevention strategies, guide health policy, and strengthen Bangladesh's research capacity in chronic disease epidemiology.

BELIEVE is creating one of South Asia's richest epidemiological bioresources — a platform that will keep generating prevention-relevant evidence for decades to come.

Prof. Sohel Reza Choudhury
Principal Investigator · NHFH&RI
Study Setting

Where BELIEVE happens

The BELIEVE-Urban cohort spans the dense urban wards of Mirpur in northern Dhaka — a population of ~2 million within one of the world's most rapidly urbanising megacities. Participants were recruited across 31,713 households in the Mirpur catchment area.

~2.0M
Mirpur population
31,713
Catchment households
59,844
Participants enrolled
3
Follow-up rounds
Why Mirpur

Mirpur's density, demographic diversity and rapidly changing risk environment make it an ideal urban laboratory to study how NCDs emerge in low- and middle-income settings — and how prevention strategies can scale to the rest of Bangladesh.

Study Design

5 data streams — one cohort

Every participant contributes across complementary data streams — from behavioural questionnaires to genomic analyses — enabling the study of social, environmental and biological determinants of disease side by side.

01

Questionnaire

>300 variables

Detailed interviews covering demographics, socioeconomic status, behavioural risk factors, medical history, and environmental exposures for every enrolled participant.

02

Anthropometry & BP

Clinical measurements

Standardised anthropometric assessments, blood pressure readings, and behavioural risk factor profiling captured at baseline and each follow-up wave.

03

Biological Samples

Serum · Plasma · Whole blood · Nail

A long-term biobank of serum, plasma, whole blood and nail samples enabling biochemical testing and molecular epidemiology for decades to come.

04

Genomics & Multi-omics

Advanced molecular analyses

Genomic, proteomic and metabolomic profiling of stored specimens to uncover biological pathways underlying cardiovascular and metabolic diseases.

05

Longitudinal Follow-up

MI · Stroke · Diabetes · Cancer

Periodic follow-up rounds track incident events and risk-factor trajectories. Round 3 is currently under way with around 50% of participants already reassessed.

Nested Sub-study

Nightingale Dried Blood Spot (DBS) pilot

Approximately 2,000 participants provided paired DBS and venous blood samples to assess the feasibility and validity of dried-blood testing for large-scale epidemiological surveillance across Bangladesh.

~2k
Paired samples
The Journey

A decade of evidence building

From the first ethical clearance in 2015 to active Round 3 follow-up today — every milestone of the BELIEVE-Urban cohort.

2015
Milestone 01
2015 · Step 01

Ethical approval

BMRC/NREC first clearance granted (Oct 2015), laying the regulatory foundation.

2016
Milestone 02
2016 · Step 02

Cohort initiated

BELIEVE-Urban enrollment launched in Mirpur, Dhaka through an NHFH&RI × Cambridge collaboration.

2017–2019
Milestone 03
2017–2019 · Step 03

Baseline completed

59,844 participants from 31,713 households enrolled with questionnaire, clinical and biospecimen data.

2020–2023
Milestone 04
2020–2023 · Step 04

Follow-up rounds

Periodic follow-up waves track incident events and changing risk profiles.

2024
Milestone 05
2024 · Step 05

Cohort profile published

Study design and baseline characteristics published in BMJ Open.

2025 → Present
Milestone 06
2025 → Present · Step 06

Round 3 follow-up

Third follow-up wave under way — ~50% of participants already reassessed.

Currently active
Round 3 follow-up in progress
~50% of participants already reassessed
50%
Round 3
Impact & Voice

Evidence that shapes prevention in Bangladesh

Policy Outcome

The BELIEVE cohort provides evidence to support national strategies for the prevention and control of cardiovascular and other non-communicable diseases in Bangladesh.

Largest
NCD bioresource in BD
Longitudinal
MI · Stroke · Diabetes · Cancer
Multi-omics
Genomics + Proteomics
Cross-cohort
UK × BD collaboration
Community Voice

By engaging tens of thousands of residents in Mirpur, the study has created an opportunity for participants to learn more about their own health — through blood-pressure checks and other clinical assessments — and to contribute to research that aims to improve the health of future generations in Bangladesh. Many participants have expressed appreciation for increasing awareness of cardiovascular risk factors, including hypertension and diabetes, within their community.

Synthesised from BELIEVE community engagement notes
For Researchers

Cite this cohort

If the BELIEVE-Urban Study supports your work, please cite the canonical cohort profile paper below.

APA citation

Choudhury SR, Danesh J, Di Angelantonio E, et al. (2024). Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and non-vascular Events (BELIEVE) cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2024-088338

BibTeX
@article{choudhurysr2024,
  title   = {Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and non-vascular Events (BELIEVE) cohort study},
  author  = {Choudhury SR, Danesh J, Di Angelantonio E, et al.},
  journal = {BMJ Open},
  year    = {2024},
  doi     = {10.1136/bmjopen-2024-088338},
  url     = {https://doi.org/10.1136/bmjopen-2024-088338},
}
Leadership

A cross-continental research team

Prof. Sohel Reza Choudhury
BD
Principal Investigator (Bangladesh)

Prof. Sohel Reza Choudhury

Professor & Head, Department of Epidemiology and Research, National Heart Foundation Hospital & Research Institute, Dhaka

Prof. John Danesh
UK
Principal Investigator (UK)

Prof. John Danesh

University of Cambridge, United Kingdom

Prof. Emanuele Di Angelantonio
UK
Co-Principal Investigator

Prof. Emanuele Di Angelantonio

University of Cambridge, United Kingdom

Partners & Affiliations

An international research consortium

BELIEVE-Urban is powered by a partnership between Bangladesh's leading cardiovascular research institute, the University of Cambridge, and a network of funders, ethics bodies, and scientific collaborators.

Governance & Compliance

Funding & ethical oversight

BELIEVE operates under continuous ethical review and is funded through competitive international research grants — every study round is independently approved.

Primary Funder
UK

UK Medical Research Council (MRC) / UKRI

Funded through the UKRI Global Challenge Research Fund via the CAPABLE consortium, University of Cambridge, UK.

Consortium
CAPABLE
Scheme
Global Challenge
Prof. Sohel Reza Choudhury
Principal Investigator
Prof. Sohel Reza Choudhury
Professor & Head, Department of Epidemiology and Research
National Heart Foundation Hospital & Research Institute, Dhaka
IRB Approvals
Bangladesh

BMRC & BMU/BSMMU

Approved by the Bangladesh Medical Research Council (BMRC) and Bangladesh Medical University (BMU, formerly BSMMU).

7
Clearances
2
IRB Bodies
10+
Years active
BMRC/NREC/2013–2016/390 · 15 Oct 2015#01
BMRC/NREC/2016–2019/243 · 07 Jun 2017#02
BSMMU/2019/1185#03
BSMMU/2022/2069#04
BSMMU/2024/803(A)#05
BSMMU/2024/11905#06
BMU/2025/17318#07
Declaration of Helsinki
|
Informed consent obtained from every participant · Data de-identified for analysis

Follow the BELIEVE journey

For the latest news, publications and community updates from the BELIEVE-Urban Study, visit the official study website.

believestudy-bangladesh.orgRead publications